c-Kit Deficiency Promotes Expansion of Hematopoietic Stem Cells from GFG-Derived iPSCs
(A) Strategy to induce HSCs from iPSCs using c-Kit deficient host mice. iPSCs were injected subcutaneously and Dox administered for 4 weeks to induce GFG expression (as in Figure 1B). Host mice were then administered polyI:C at weeks 14–16. At 20 weeks, WBMCs from teratoma-bearing mice were transplanted into irradiated mice, and PB/BM chimerism tracked. Secondary transplantations were performed at 16 weeks after the primary transplantation.
(B) Representative flow cytometric plots for CD45.1 and CD45.2 expression in the PB from teratoma-bearing C57BL/6 and c-Kit-deficient mice after 4–6 weeks poly(I:C) administration.
(C) Percentage CD45.1+ chimerism in the PB (left) and BM (right). Data are the means ± SD from two independent experiments (n = 6). ∗∗p < 0.005, ∗p < 0.05.
(D) Percentage of (GFG iPSC-derived) CD45.1+ PB chimerism of in primary and secondary recipient mice (n = 5).
(E and F) Colony potential of 2.0 × 104 host CD45.2+ and GFG-derived CD45.1+ BM cells of secondary recipients, after 11-day culture in Methocult. Total number of colonies displayed in (E) and colony type displayed in (F). Data are means ± SD from two independent experiments (n = 3). Colony cells were morphologically identified as neutrophils (n), macrophages (m), erythroblasts (E) and megakaryocytes (M). ∗∗p < 0.005.
(G) Representative flow cytometric plots and gating for the Kit+Sca1+Lineage− fraction within the BM of secondary recipient mice transplanted with GFG teratoma-derived blood cells 24 weeks post-transplantation. Lin−, lineage negative cells; KSL, Lin−Kit+Sca1+ cells.